<?xml version='1.0' encoding='utf-8'?>
<document id="20183431"><sentence text="Drug-drug interaction prediction assessment." /><sentence text="Model-based drug-drug interaction (DDI) is an important in-silico tool to assess the in vivo consequences of in vitro DDI" /><sentence text=" Before its general application to new drug compounds, the DDI model is always established from known interaction data" /><sentence text=" For the first time, tests for difference and equivalent tests are implemented to compare reported and model-base simulated DDI (log AUCR) in the sample mean and variance" /><sentence text=" The biases and predictive confidence interval coverage probabilities are introduced to assess the DDI prediction performance" /><sentence text=" Sample size and power guidelines are developed for DDI model simulations" /><sentence text=" These issues have never been discussed in trial simulation studies to investigate DDI prediction" /><sentence text=" A ketoconazole (KETO)/midazolam (MDZ) example is employed to demonstrate these statistical methods"><entity charOffset="3-15" id="DDI-PubMed.20183431.s8.e0" text="ketoconazole" /><entity charOffset="17-21" id="DDI-PubMed.20183431.s8.e1" text="KETO" /><entity charOffset="23-32" id="DDI-PubMed.20183431.s8.e2" text="midazolam" /><entity charOffset="34-37" id="DDI-PubMed.20183431.s8.e3" text="MDZ" /><pair ddi="false" e1="DDI-PubMed.20183431.s8.e0" e2="DDI-PubMed.20183431.s8.e0" /><pair ddi="false" e1="DDI-PubMed.20183431.s8.e0" e2="DDI-PubMed.20183431.s8.e1" /><pair ddi="false" e1="DDI-PubMed.20183431.s8.e0" e2="DDI-PubMed.20183431.s8.e2" /><pair ddi="false" e1="DDI-PubMed.20183431.s8.e0" e2="DDI-PubMed.20183431.s8.e3" /><pair ddi="false" e1="DDI-PubMed.20183431.s8.e1" e2="DDI-PubMed.20183431.s8.e1" /><pair ddi="false" e1="DDI-PubMed.20183431.s8.e1" e2="DDI-PubMed.20183431.s8.e2" /><pair ddi="false" e1="DDI-PubMed.20183431.s8.e1" e2="DDI-PubMed.20183431.s8.e3" /><pair ddi="false" e1="DDI-PubMed.20183431.s8.e2" e2="DDI-PubMed.20183431.s8.e2" /><pair ddi="false" e1="DDI-PubMed.20183431.s8.e2" e2="DDI-PubMed.20183431.s8.e3" /></sentence><sentence text=" Based on published KETO and MDZ pharmacokinetics data and their in vitro inhibition rate constant data, current model-based DDI prediction underpredicts the area under concentration curve ratio (AUCR) and its between-subject variance compared to the reported study"><entity charOffset="20-22" id="DDI-PubMed.20183431.s9.e0" text="KETO" /><entity charOffset="29-31" id="DDI-PubMed.20183431.s9.e1" text="MDZ" /><pair ddi="false" e1="DDI-PubMed.20183431.s9.e0" e2="DDI-PubMed.20183431.s9.e0" /><pair ddi="false" e1="DDI-PubMed.20183431.s9.e0" e2="DDI-PubMed.20183431.s9.e1" /></sentence><sentence text="" /></document>